Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antibacterial Cross-Monograph Ingredients, Indications Urged By CTFA/SDA

This article was originally published in The Tan Sheet

Executive Summary

Combination indications for antimicrobial products formulated with active ingredients from the first aid monograph or skin protectant monograph should be allowed by FDA, industry groups advise in a June 1 citizen petition.

You may also be interested in...



Antimicrobial Data Support CTFA/SDA Performance Criteria - Petition

A comprehensive literature review of topical antimicrobial data "corroborates" the suitability of the product performance criteria advocated by industry, the Cosmetic, Toiletry & Fragrance Association and Soap & Detergent Association maintain in an Aug. 6 joint submission to FDA.

Antimicrobial Data Support CTFA/SDA Performance Criteria - Petition

A comprehensive literature review of topical antimicrobial data "corroborates" the suitability of the product performance criteria advocated by industry, the Cosmetic, Toiletry & Fragrance Association and Soap & Detergent Association maintain in an Aug. 6 joint submission to FDA.

Antimicrobial Data Support CTFA/SDA Performance Criteria - Petition

A comprehensive literature review of topical antimicrobial data "corroborates" the suitability of the product performance criteria advocated by industry, the Cosmetic, Toiletry & Fragrance Association and Soap & Detergent Association maintain in an Aug. 6 joint submission to FDA.

Related Content

Topics

UsernamePublicRestriction

Register

PS092638

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel